Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies.
In a historic trading session on Tuesday, cannabis stocks soared following the DEA's decision to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act.
Nikola encouraged shareholders to vote "Yes" to all five proposals, including Proposal 2 for a reverse stock split. The company said it anticipates a positive impact from the reverse stock split which would address potential delisting concerns and reset the company's financial foundation.
Gauss AI and Heartdub are jointly developing Gausspeed, a generative artificial intelligence (AIGC) platform designed for film production, video generation, and other content creation within the digital entertainment sector. The companies are leveraging the Nvidia Omniverse and Nvidia RTX GPUs in development.
Key Takeaways:
CMGE said it has formed a partnership with Guangzhou Chaojing Investment aimed at tapping the latter’s strong position in e-sports
CMGE’s shares rose 3.2% on the news and have rallied 30% in the past week on renewed investors interest in the gaming sector after a prolonged crackdown that is now easing
ZyVersa Therapeutics shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities in patients with Alzheimer's Disease.